Two single-dose studies were conducted in Japan and Europe to compare the pharmacokinetic ( PK ) and pharmacodynamic ( PD ) profiles of new insulin glargine 300U/ml ( Gla-300 ) and insulin glargine 100U/ml ( Gla-100 ) in people with type 1 diabetes mellitus .